Items where Author is "I.S., Ismail,"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article | Other
Number of items: 49.

Article

I.S., Ismail, (2011) Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects. Cardiovascular Diabetology, 10. p. 23.

I.S., Ismail, (2011) Clustering of metabolic syndrome factors in Malaysian population: Asian Criteria revisited. The International Journal of Collaborative Research on Internal Medicine & Public Health, 3 (8). pp. 655-664.

I.S., Ismail, (2011) Evaluation of N949;-(Carboxymethyl)lysine and Lipid Peroxidation in Multiethnic Malaysian Subjects with Type 2 Diabetes Mellitus. SCIENTIFIC RESEARCH AND ESSAYS, 6 (9). pp. 1957-1962.

I.S., Ismail, (2011) Prevalence of Abnormal Glucose Tolerance and Their Risk Factors in Urban and Rural Malaysia. Diabetes Care, 34 (6). pp. 1362-1364.

I.S., Ismail, (2011) Prevalence of Overweight and Obesity among Adult Malaysians: an update. pp. 35-41.

I.S., Ismail, (2011) Prevalence of metabolic syndrome and its risk factors in adult Malaysians: results of a nationwide survey. Diabetes Research and Clinical Practice, 91 (2). pp. 239-245.

I.S., Ismail, (2010) Is F2-isoprostane a biological marker for the early onset of type 2 diabetes mellitus. International Journal of Diabetes in Developing Countries, 30 (3). pp. 167-170.

I.S., Ismail, (2010) Type 2 Diabetes and Vascular Complications: A pathophysiologic view. Biomedical Research, 21 (2). pp. 147-155.

I.S., Ismail, (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. New England Journal of Medicine, 331 (14). pp. 904-909.

I.S., Ismail, (1993) Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback. Clinical Endocrinology, 38 (2). pp. 149-157.

I.S., Ismail, (1993) Reduced sampling protocols in estimation of insulin sensitivity and glucose effectiveness using the minimal model in NIDDM. Diabetes, 42 (11). pp. 1635-1641.

I.S., Ismail, (1991) Effects of ambient glycaemic state on growth hormone responsiveness in insulin-dependent diabetes. Clinical Endocrinology, 35 (6). pp. 499-504.

Other

I.S., Ismail, (2005) Association between c-reactive protein and features of the Metabolic Syndrome in a rural population of Malaysia - a preliminary analysis. UNSPECIFIED.

I.S., Ismail, (2001) A re-evaluation of the plasma sialic acid determination using the periodate-resorcinol method against the enzymatic method. UNSPECIFIED.

I.S., Ismail, (2001) Cardiovascular Risk Factor Clustering in Type 2 Diabetes Mellitus / Glucose Intolerant Malaysians. UNSPECIFIED.

I.S., Ismail, (2001) Concentration of plasma sialic acid in the offspring of one type 2 diabetic parent. UNSPECIFIED.

I.S., Ismail, (2001) Lipid abnormalities in subjects with type 2 diabetes mellitus in Malaysia. UNSPECIFIED.

I.S., Ismail, (2001) Use of the Insulin Tolerance Test and Oral Glucose Tolerance Test in the assessment of insulin release and Insulin sensitivity: A comparison with HOMA and QUICKI. UNSPECIFIED.

I.S., Ismail, (2000) Advanced glycosylation end-products and lipid peroxides in diabetes patients with retinopathy and microalbuminuria. UNSPECIFIED.

I.S., Ismail, (2000) Clinical, biochemical and immunological characterisation of young Asian patients with diabetes mellitus. UNSPECIFIED.

I.S., Ismail, (2000) Comparison between the 1997 ADA criteria versus the 1998 WHO recommendation for the diagnosis of diabetes mellitus in a Malaysian population. UNSPECIFIED.

I.S., Ismail, (2000) Diabetes control in ASEAN: Pitfalls and Research Direction. UNSPECIFIED.

I.S., Ismail, (2000) Measurement of insulin sensitivity with insulin tolerance test in diabetic subjects. UNSPECIFIED.

I.S., Ismail, (2000) Progression of glucose intolerance and diabetes mellitus in a 10 year follow- up study of non-communicable diseases in a rural population. UNSPECIFIED.

I.S., Ismail, (2000) The features of insulin resistance syndrome in subjects with type 2 diabetes mellitus. UNSPECIFIED.

I.S., Ismail, (1999) Determinants of dyslipidaemia in young diabetics in Malaysia. UNSPECIFIED.

I.S., Ismail, (1999) Determinants of dyslipidaemia in young diabetics in Malaysia. UNSPECIFIED.

I.S., Ismail, (1999) Differences between the new ADA and WHO criteria for the diagnosis of diabetes. UNSPECIFIED.

I.S., Ismail, (1999) Obesity In Young Diabetic Patients In Malaysia. UNSPECIFIED.

I.S., Ismail, (1999) Socioeconomic status, not facilities for diabetes care, are determinants of diabetic control. UNSPECIFIED.

I.S., Ismail, (1997) Cabergoline in hyperprolactinaemic patients unresponsive or intolerant to standard therapy. UNSPECIFIED.

I.S., Ismail, (1997) Glutamic Acid Decarboxylase antibodies amongst Young Malaysian Diabetics: Its Clinical Significance. UNSPECIFIED.

I.S., Ismail, (1997) How Good is Diabetic Control in Malaysian Hospitals? UNSPECIFIED.

I.S., Ismail, (1997) Influence of treatment on the metabolic and hormonal responses in non-insulin dependent diabetes mellitus (NIDDM) patients - A 24 month follow-up study. UNSPECIFIED.

I.S., Ismail, (1997) Pancreatic reserve and GAD antibodies in Malaysian young diabetics. UNSPECIFIED.

I.S., Ismail, (1995) CHOLINERGIC MODULATION OF IN-VITRO HYPOTHALAMIC NEUROPEPTIDE RELEASE IN GOTO-KAKIZAKI (GK) AND NORMAL RATS. UNSPECIFIED.

I.S., Ismail, (1994) Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects. UNSPECIFIED.

I.S., Ismail, (1993) Abnormal hypothalamic regulation of GH secretion in the Goto-Kakizaki (GK) rats: evidence for increased hypothalamic somatostatinergic tone. UNSPECIFIED.

I.S., Ismail, (1993) Cabergoline versus bromocriptine in the treatment of hyperprolactinaemic amenorrhoea: a randomised, parallel group, multicentre, multinational, comparative study. UNSPECIFIED.

I.S., Ismail, (1993) Cholinergic blockade with pirenzepine (PIR) reduces plasma insulin (PI) and plasma glucose (PG) responses to three standard meals during a 12 hour study. UNSPECIFIED.

I.S., Ismail, (1993) Glucose, insulin and growth hormone secretory status in the Goto-Kakizaki model of diabetes. UNSPECIFIED.

I.S., Ismail, (1993) Hypothalamic cholinergic control of GH secretion in the Goto-Kakizaki (GK) rats: evidence for increased hypothalamic somatostatinergic tone. UNSPECIFIED.

I.S., Ismail, (1993) REDUCED SAMPLING PROTOCOLS AND THE INSULIN MODIFIED INTRAVENOUS GLUCOSE-TOLERANCE TEST IN TYPE-II DIABETES. UNSPECIFIED.

I.S., Ismail, (1993) THE EFFECTS OF 3-DOSE REGIMENS OF INTRANASAL INSULIN ON THE METABOLIC PROFILES OF TYPE-II DIABETIC SUBJECTS. UNSPECIFIED.

I.S., Ismail, (1992) ACUTE CHOLINERGIC BLOCKADE WITH LOW-DOSE PIRENZEPINE (PIR) REDUCES INSULIN AND GLUCOSE RESPONSES TO A MIXED MEAL IN OBESE WOMEN WITH THE POLYCYSTIC-OVARY-SYNDROME (PCOS). UNSPECIFIED.

I.S., Ismail, (1992) Cholinergic control of growth hormone (GH) responses to GH-releasing hormone (GHRH) in insulin dependent diabetics. UNSPECIFIED.

I.S., Ismail, (1992) Growth hormone (GH) autofeedback: Evidence for attenuation of effect in insulin dependent diabetics. UNSPECIFIED.

I.S., Ismail, (1992) Long term cabergoline (CAB) therapy in hyperprolactinaemic disorders: An open, uncontrolled, multicenter study. UNSPECIFIED.

I.S., Ismail, (1992) THE EFFICACY AND TOLERABILITY OF LONG TERM CABERGOLINE THERAPY IN HYPERPROLACTINAEMIC DISORDERS AN OPEN UNCONTROLLED MULTICENTER STUDY. UNSPECIFIED.

This list was generated on Sun Nov 19 02:14:11 2017 MYT.